Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by CEimpact. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CEimpact or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Pharmacist-Provided Addiction Treatment

33:19
 
Share
 

Manage episode 483671418 series 2931422
Content provided by CEimpact. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CEimpact or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Pharmacists are stepping into a critical role in addiction treatment, expanding access to life-saving medications like buprenorphine through pharmacy-based MOUD clinics. This episode examines how this innovative model is transforming care for patients with opioid use disorder and what pharmacists need to understand before considering an expansion of services in this space. Tune in to learn how pharmacist-led addiction treatment can improve patient outcomes, strengthen communities, and help combat the opioid crisis.
HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact
GUEST
Korey Kreider, PharmD
Pharmacist, Owner
Medicine Man
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the role of pharmacists in providing medication for opioid use disorder (MOUD) and the impact of pharmacy-based addiction treatment services.
2. Identify key regulatory and scope of practice considerations pharmacists must evaluate before expanding services to include addiction treatment.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-190-H01-P
Initial release date: 5/19/2025
Expiration date: 5/19/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

  continue reading

Chapters

1. Introduction to Opioid Crisis (00:00:00)

2. Challenges in Addiction Access (00:05:12)

3. Buprenorphine's Role in Addiction (00:14:09)

4. Pharmacist Prescribing Authority (00:18:07)

5. Patient Outcomes & Primary Care (00:26:22)

6. Reimbursement & Training Opportunities (00:31:30)

337 episodes

Artwork
iconShare
 
Manage episode 483671418 series 2931422
Content provided by CEimpact. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CEimpact or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Pharmacists are stepping into a critical role in addiction treatment, expanding access to life-saving medications like buprenorphine through pharmacy-based MOUD clinics. This episode examines how this innovative model is transforming care for patients with opioid use disorder and what pharmacists need to understand before considering an expansion of services in this space. Tune in to learn how pharmacist-led addiction treatment can improve patient outcomes, strengthen communities, and help combat the opioid crisis.
HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact
GUEST
Korey Kreider, PharmD
Pharmacist, Owner
Medicine Man
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the role of pharmacists in providing medication for opioid use disorder (MOUD) and the impact of pharmacy-based addiction treatment services.
2. Identify key regulatory and scope of practice considerations pharmacists must evaluate before expanding services to include addiction treatment.
0.05 CEU/0.5 Hr
UAN: 0107-0000-25-190-H01-P
Initial release date: 5/19/2025
Expiration date: 5/19/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

  continue reading

Chapters

1. Introduction to Opioid Crisis (00:00:00)

2. Challenges in Addiction Access (00:05:12)

3. Buprenorphine's Role in Addiction (00:14:09)

4. Pharmacist Prescribing Authority (00:18:07)

5. Patient Outcomes & Primary Care (00:26:22)

6. Reimbursement & Training Opportunities (00:31:30)

337 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play